FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Three Charged with Falsifying Clinical Trial Data

A Miami grand jury charges three defendants for their roles in an alleged scheme to fabricate and falsify clinical drug trial data submitted to FDA.

latest-news-card-1
Human Drugs

FDA Publishes ICH E19 Guideline

FDA publishes the International Council for Harmonization E19 guideline on selective safety data collection in some circumstances.

latest-news-card-1
Human Drugs

FDA Seeks Covis Info for Makena Hearing

CDER asks an FDA hearing officer to direct Covis to provide additional information on items from its final briefing materials for an upcoming hearing ...

Biologics

GSK Respiratory Syncytial Virus Vaccine Highly Efficacious

GlaxoSmithKline says its investigational adult respiratory syncytial virus vaccine candidate was highly effective in a Phase 3 trial, with a favorable...

latest-news-card-1
Human Drugs

FDA Says Adderall is in Shortage

FDA says Teva manufacturing delays have led to a shortage of Adderalls immediate-release formulation.

latest-news-card-1
Human Drugs

CMC Comparability Protocol Guidance

FDA publishes a final guidance on using comparability protocols for postapproval changes in chemistry, manufacturing, and controls information in NDAs...

latest-news-card-1
Human Drugs

Distributed Manufacturing Discussion Paper

FDA solicits input on a discussion paper raising regulatory issues and questions about direct manufacturing and point-of-care manufacturing of drugs.

latest-news-card-1
Marketing

OPDP Wants to Research Drug Name Interpretation

The CDER Office of Prescription Drug Promotion says it wants to research how consumers and healthcare providers interpret prescription drug names.

latest-news-card-1
Human Drugs

Regener-Eyes Illegally Selling Dry Eye Product

FDA says Palm Harbor, FL-based Regener-Eyes is illegally marketing its Regener-Eyes Ophthalmic Solution.

latest-news-card-1
Federal Register

FDA Extends Comment Period on LASIK Labeling Guide

Federal Register notice: FDA extends the comment period for a draft guidance entitled Laser-Assisted In Situ Keratomileusis (LASIK) Lasers Patient La...